Biomaterial-Based Particulate Drug Carriers - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 19

36. Xianjun, Y.X. et al. (2010) Targeted drug delivery in pancreatic cancer.
BBA Rev. Cancer , 1805, pp. 97-104.
37. Garanger, E., Didier, B. Pascal, D. (2007) Tumor targeting with RGD
peptide ligands-design of new molecular conjugates for imaging and
therapy of cancers, Anti-Cancer Agents Med. Chem ., 7, pp. 552-558.
38. Vivès, E., Schmidt, J., Pèlegrin, A. (2008) Cell-penetrating and cell-
targeting peptides in drug delivery, BBA Rev. Cancer , 1786, 126-138.
39. Dekel, Y., Glucksam, Y., Margalit, R. (2010) Novel fibrillar insulin
formulations for oral administration: formulation and in vivo studies
in diabetic mice, J. Cont. Rel ., 143, pp. 128-135.
40. Platt, V.M., Szoka, F.C. (2008). Anticancer therapeutics: targeting
macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan
receptor, Mol. Pharm ., 5, pp. 474-486.
41. Kanellakopoulou, K., Giamarellos-Bourboulis, E.J (2000) Carrier
systems for the local delivery of antibiotics in bone infections, Drugs ,
59, pp. 1223-1232.
42. Zhang J-S., Liu, F., Huang, L. (2005) Implications of pharmacokinetic
behavior of lipoplex for its inflammatory toxicity, Adv. Drug Deliv. Rev .,
57, pp. 689-698.
43. Lv, H. et al. (2006). Toxicity of cationic lipids and cationic polymers in
gene delivery, J. Cont. Rel ., 114, pp. 100-109.
44. de Ilarduyaa, C.T., Sunb, Y., Duzgunes, N. (2010) Gene delivery by
lipoplexes and polyplexes, Eur. J. Pharm . Sci., 40, pp. 159-170.
45. Alving, C.R. et al. (1978) Improved therapy of experimental
leishmaniasis by use of a liposome-encapsulated antimonail drug, Life
Sci ., 22, pp. 1021-1026.
46. Raz, A. et al. (1981) Biochemical, morphological, and ultrastructural
studies on the uptake of liposomes by murine macrophages, Cancer
Res ., 41, pp. 487-494.
47. Isaiah, I.J. et al. (1981) The role of plasma membrane receptors and
the kinetics of macrophage activation by lymphokines encapsulated in
liposomes, Cancer Res ., 41, pp. 495-504.
48. Kirsh, R., Bugelski, P.J., Poste, G. (1987) Drug delivery to macrophages
for the therapy of cancer and infectious diseases, Ann. N.Y. Acad. Sci .,
507, pp. 141-154.
49. Nardin, A. et al. (2006) Liposomal muramyl tripeptide
phosphatidylethanolamine: targeting and activating macrophages for
adjuvant treatment of osteosarcoma, Curr. Cancer Drug Targets , 6, pp.
123-133.
50. Bhowmick, S., Mazumdar, T., Sinha, R.. Ali, N. (2010), Comparison
of liposome based antigen delivery systems for protection against
Leishmania donovani , J. Control. Release , 141, pp. 199-207.